[Contrast media in magnetic resonance tomography. A review. 2. Biological basis, research technic and clinical application of gadolinium-DTPA in the diagnosis of intracranial tumors].
The early results of the use of the MR specific contrast medium gadolinium-DTPA in 40 patients with intracranial tumours are reported. Optimal pulse sequences, contrast dose and timing are discussed. The relationship between the blood-brain barrier and contrast distribution within tumour tissue is elaborated. The clinical significance of the application of contrast agents in the diagnosis of brain tumours is evaluated.
Felix
R
R
Schörner
W
W
Laniado
M
M
Semmler
W
W
D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000556:secondary; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D009447:Neuroblastoma / Q000175:diagnosis; D009464:Neuroma, Acoustic / Q000175:diagnosis; D004369:Pentetic Acid
D004369:Pentetic Acid
Kontrastmittel in der magnetischen Resonanztomographie. Eine Ubersicht. Teil 2: Biologische Grundlagen, Untersuchungstechnik und klinische Anwendung von Gadolinium-DTPA in der Diagnostik intrakranieller Tumoren.